The Rest Of Europe Clinical Decision Support Systems (CDSS) Market was valued at $112.3 Million in 2025 and projected to reach to $185.8 Million by 2030, representing a compound annual growth rate of 10.6%. Rest Of Europe's Clinical Decision Support Systems market is positioned for sustained growth through 2030, driven by healthcare providers' need to improve clinical outcomes and operational efficiency.
Rest Of Europe's CDSS market is expanding at 10.6% CAGR, outpacing the global average of 9.6%, reflecting accelerated healthcare digitalization across smaller European markets.
The market is valued at USD 112.3 million in 2025 and is projected to grow to USD 185.8 million by 2030, representing a 65.4% increase over the five-year forecast period.
Rest Of Europe is witnessing increased investment in healthcare IT infrastructure, driven by EU regulatory compliance requirements and national digital health initiatives across emerging European economies.
Growing physician demand for AI-powered diagnostic support and evidence-based decision-making tools is driving CDSS implementation in hospitals, clinics, and primary care facilities across the region.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ACTIVE CDSS (Interactivity Level) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.6% from 2025 to 2030 |
| Largest Segment | INTEGRATED CDSS (Product) |
| Market Size Base Year (Billions) | ~USD 2.46 (2025) |
| Revenue Forecast (Billions) | ~USD 3.89 (2030) |
| Segments Covered | Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting |
8 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Microbiology (culture media, VITEK 2, VITEK MS, BACT/ALERT, ETEST, API, CHEMUNEX, TEMPO, BIOBALL),Molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS, GENE-UP, VERIFLOW),Immunoassays and CLIA (VIDAS, Hybiome), |
| CONVERGYS | United States | Private Company | Customer care and technical support,Analytics and performance management,Collections and revenue cycle, |
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Patient Support Systems (beds, surfaces, mobility),Front Line Care (monitoring, diagnostics, respiratory),Surgical Solutions (tables, lights, pendants, positioning), |
| IBM CORPORATION | United States | Public Company | Software (Hybrid Cloud & AI Platforms, Data, Automation),Consulting (Strategy, Technology Services, Intelligent Operations),Infrastructure (Servers, Storage, Hybrid Cloud Infrastructure Services), |
| WOLTERS KLUWER N.V. | Netherlands | Public Company | Health (clinical and GenAI solutions),Tax & Accounting (AI-powered software and research),Financial & Corporate Compliance, |
| ORACLE | United States | Public Company | Cloud applications (Fusion, NetSuite, Oracle Health, CX),Cloud infrastructure and database (OCI, Autonomous DB, MySQL),License support and on-premise licenses, |
| VERADIGM LLC | United States | Public Company | Ambulatory EHR and Practice Management (incl. ePrescribe, Practice Fusion, Veradigm EHR),Revenue Cycle, Clearinghouse, and Coding Services (Payerpath, RCM, Coding),Payer and Risk Adjustment Analytics (Health Equity, Risk Mitigator, Utilization Analytics), |
| ATHENAHEALTH | United States | Private Company | athenaOne (EHR + practice management + patient engagement),athenaIDX and broader revenue cycle management services,Payer solutions and advisory services, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, Diagnostic X-ray, Ultrasound),Image Guided Therapy (Systems and Devices),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care), |
| MEDICAL INFORMATION TECHNOLOGY, INC. | United States | Private Company | Core acute-care EHR platforms,Laboratory and clinical department software,Financials, billing, and accounting, |
| NEXTGEN HEALTHCARE, INC. | United States | Private Company | Enterprise EHR (NextGen Enterprise EHR),Enterprise Practice Management (NextGen Enterprise PM),RCM and Managed Services, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
BIOMERIEUX S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the healthcare and diagnostics sector.
CONVERGYS is a United States-based private company founded in 1998 with 110,000 employees. The company provides business services and customer management solutions.
HILL-ROM HOLDINGS, INC. is a United States-based private company founded in 1915 with 10,000 employees. The company operates in the medical device and healthcare equipment industry.
IBM CORPORATION is a United States-based public company founded in 1911 with 264,300 employees. The company is a global leader in information technology, software, and business services.
WOLTERS KLUWER N.V. is a Netherlands-based public company founded in 1836 with 19,812 employees. The company provides professional information, software solutions, and services for healthcare, legal, and business sectors.
ORACLE is a United States-based public company founded in 1977 with 141,000 employees. The company is a global leader in database software, cloud computing, and enterprise solutions.
VERADIGM LLC is a United States-based public company founded in 1986 with 2,300 employees. The company provides healthcare data and analytics solutions.
ATHENAHEALTH is a United States-based private company founded in 1997 with 5,156 employees. The company provides cloud-based healthcare software and services for medical practices and hospitals.
KONINKLIJKE PHILIPS N.V. is a Netherlands-based public company founded in 1891 with 64,317 employees. The company is a global leader in healthcare technology, consumer electronics, and lighting solutions.
MEDICAL INFORMATION TECHNOLOGY, INC. is a United States-based private company founded in 1968 with 3,531 employees. The company develops healthcare information systems and electronic medical record software.
NEXTGEN HEALTHCARE, INC. is a United States-based private company founded in 1974 with 2,783 employees. The company provides healthcare IT solutions and practice management software.
SIEMENS HEALTHINEERS AG is a Germany-based public company founded in 1896 with 72,369 employees. The company is a global leader in medical imaging, diagnostics, and healthcare technology solutions.
The Rest Of Asia Pacific Clinical Decision Support Systems market is valued at USD 112.3 million in 2025, representing a significant segment within the broader Asia Pacific healthcare technology ecosystem.
Rest Of Asia Pacific's CDSS market is forecast to reach USD 185.8 million by 2030, reflecting a compound annual growth rate of 10.6% over the five-year forecast period.
Rest Of Asia Pacific's CDSS market is projected to grow at a CAGR of 10.6% from 2025 to 2030, exceeding the global average growth rate and indicating strong regional momentum.
Rest Of Asia Pacific's CDSS market growth is driven by healthcare digitalization initiatives, increasing AI adoption in clinical settings, expanding hospital infrastructure, and rising physician demand for decision support tools.
Rest Of Asia Pacific's 10.6% CAGR outpaces the global average of 9.6%, positioning the region as a high-growth market with significant expansion potential relative to mature healthcare IT markets.
The study involved five major activities to estimate the current size of the clinical decision support systems (CDSS) market. Exhaustive secondary research was conducted to collect information on the market and its subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
This research study relied extensively on secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings. Secondary research was used to identify and collect valuable information for this study. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends down to the bottom-most level, and key market & technology developments. A database of the key industry leaders was also prepared using secondary research.
Some of the key secondary sources referred to for this study include:
Extensive primary research was conducted after acquiring basic knowledge of the global CDSS market through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and the supply side (C- and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. This primary data was collected through questionnaires, emails, online surveys, personal interviews, and telephone interviews. In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from core and related industries, solution providers, technology vendors, system integrators, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess prospects. Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

Note 1: C-level primaries include CEOs, CFOs, and CoOs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the CDSS market. These methods were also used extensively to estimate the size of various market subsegments.

After determining the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides in the CDSS market.
Clinical decision support systems are designed to enhance clinical decision-making and improve healthcare outcomes. These Healthcare Information Technology (HCIT) systems provide timely, patient-specific information to healthcare providers, enabling appropriate clinical decisions based on the circumstances. These platforms help ensure that healthcare professionals provide evidence-based, high-value care to patients.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Clinical Decision Support Systems (CDSS) Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report